Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Administrative database as a source for assessment of systemic lupus erythematosus prevalence: Estonian experience.

Otsa K, Talli S, Harding P, Parsik E, Esko M, Teepere A, Tammaru M.

BMC Rheumatol. 2019 Jul 25;3:26. doi: 10.1186/s41927-019-0074-7. eCollection 2019.

2.

Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis.

Salaffi F, Di Carlo M, Vojinovic J, Tincani A, Sulli A, Soldano S, Andreoli L, Dall'Ara F, Ionescu R, Simić Pašalić K, Balčune I, Ferraz-Amaro I, Tlustochowicz M, Butrimienė I, Punceviciene E, Toroptsova N, Grazio S, Morović-Vergles J, Masaryk P, Otsa K, Bernardes M, Boyadzhieva V, Cutolo M.

Joint Bone Spine. 2018 May;85(3):317-322. doi: 10.1016/j.jbspin.2017.05.020. Epub 2017 May 24.

PMID:
28549945
3.

European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO).

Vojinovic J, Tincani A, Sulli A, Soldano S, Andreoli L, Dall'Ara F, Ionescu R, Pasalic KS, Balcune I, Ferraz-Amaro I, Tlustochowicz M, Butrimiene I, Punceviciene E, Toroptsova N, Grazio S, Morovic-Vergles J, Masaryk P, Otsa K, Bernardes M, Boyadzhieva V, Salaffi F, Cutolo M.

Autoimmun Rev. 2017 May;16(5):548-554. doi: 10.1016/j.autrev.2017.03.002. Epub 2017 Mar 6. Review.

PMID:
28279841
4.

Prevalence and incidence of systemic lupus erythematosus in the adult population of Estonia.

Otsa K, Talli S, Harding P, Parsik E, Esko M, Teepere A, Tammaru M.

Lupus. 2017 Sep;26(10):1115-1120. doi: 10.1177/0961203316686705. Epub 2017 Jan 6.

PMID:
28059020
5.

Associations Between Five Important Domains of Health and the Patient Acceptable Symptom State in Rheumatoid Arthritis and Psoriatic Arthritis: A Cross-Sectional Study of 977 Patients.

Puyraimond-Zemmour D, Etcheto A, Fautrel B, Balanescu A, de Wit M, Heiberg T, Otsa K, Kvien TK, Dougados M, Gossec L.

Arthritis Care Res (Hoboken). 2017 Oct;69(10):1504-1509. doi: 10.1002/acr.23176. Epub 2017 Sep 6.

6.

Determinants of Patient-Physician Discordance in Global Assessment in Psoriatic Arthritis: A Multicenter European Study.

Desthieux C, Granger B, Balanescu AR, Balint P, Braun J, Canete JD, Heiberg T, Helliwell PS, Kalyoncu U, Kvien TK, Kiltz U, Niedermayer D, Otsa K, Scrivo R, Smolen J, Stamm TA, Veale DJ, de Vlam K, de Wit M, Gossec L.

Arthritis Care Res (Hoboken). 2017 Oct;69(10):1606-1611. doi: 10.1002/acr.23172. Epub 2017 Sep 6.

7.

Fatigue in psoriatic arthritis - a cross-sectional study of 246 patients from 13 countries.

Gudu T, Etcheto A, de Wit M, Heiberg T, Maccarone M, Balanescu A, Balint PV, Niedermayer DS, Cañete JD, Helliwell P, Kalyoncu U, Kiltz U, Otsa K, Veale DJ, de Vlam K, Scrivo R, Stamm T, Kvien TK, Gossec L.

Joint Bone Spine. 2016 Jul;83(4):439-43. doi: 10.1016/j.jbspin.2015.07.017. Epub 2016 Apr 4.

PMID:
27055727
8.

Patient global assessment in psoriatic arthritis - what does it mean? An analysis of 223 patients from the Psoriatic arthritis impact of disease (PsAID) study.

Tälli S, Etcheto A, Fautrel B, Balanescu A, Braun J, Cañete JD, de Vlam K, de Wit M, Heiberg T, Helliwell P, Kalyoncu U, Kiltz U, Maccarone M, Niedermayer D, Otsa K, Scrivo R, Smolen JS, Stamm T, Veale DJ, Kvien TK, Gossec L.

Joint Bone Spine. 2016 May;83(3):335-40. doi: 10.1016/j.jbspin.2015.06.018. Epub 2015 Dec 8.

PMID:
26677994
9.

MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study.

Peterfy C, Emery P, Tak PP, Østergaard M, DiCarlo J, Otsa K, Navarro Sarabia F, Pavelka K, Bagnard MA, Gylvin LH, Bernasconi C, Gabriele A.

Ann Rheum Dis. 2016 Jan;75(1):170-7. doi: 10.1136/annrheumdis-2014-206015. Epub 2014 Oct 29.

10.

A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative.

Gossec L, de Wit M, Kiltz U, Braun J, Kalyoncu U, Scrivo R, Maccarone M, Carton L, Otsa K, Sooäär I, Heiberg T, Bertheussen H, Cañete JD, Sánchez Lombarte A, Balanescu A, Dinte A, de Vlam K, Smolen JS, Stamm T, Niedermayer D, Békés G, Veale D, Helliwell P, Parkinson A, Luger T, Kvien TK; EULAR PsAID Taskforce.

Ann Rheum Dis. 2014 Jun;73(6):1012-9. doi: 10.1136/annrheumdis-2014-205207.

PMID:
24790067
11.

The prevalence of rheumatoid arthritis in Estonia: an estimate based on rheumatology patients' database.

Otsa K, Tammaru M, Vorobjov S, Esko M, Pärsik E, Lang K.

Rheumatol Int. 2013 Apr;33(4):955-8. doi: 10.1007/s00296-012-2473-6. Epub 2012 Jul 26.

PMID:
22833240
12.

Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative.

Gossec L, Paternotte S, Aanerud GJ, Balanescu A, Boumpas DT, Carmona L, de Wit M, Dijkmans BA, Dougados M, Englbrecht M, Gogus F, Heiberg T, Hernandez C, Kirwan JR, Mola EM, Cerinic MM, Otsa K, Schett G, Scholte-Voshaar M, Sokka T, von Krause G, Wells GA, Kvien TK.

Ann Rheum Dis. 2011 Jun;70(6):935-42. doi: 10.1136/ard.2010.142901.

PMID:
21540201
13.

Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus.

Cutolo M, Otsa K, Paolino S, Yprus M, Veldi T, Seriolo B.

Ann Rheum Dis. 2009 Mar;68(3):446-7. doi: 10.1136/ard.2008.093476. No abstract available.

PMID:
19213751
14.

Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative.

Gossec L, Dougados M, Rincheval N, Balanescu A, Boumpas DT, Canadelo S, Carmona L, Daurès JP, de Wit M, Dijkmans BA, Englbrecht M, Gunendi Z, Heiberg T, Kirwan JR, Mola EM, Matucci-Cerinic M, Otsa K, Schett G, Sokka T, Wells GA, Aanerud GJ, Celano A, Dudkin A, Hernandez C, Koutsogianni K, Akca FN, Petre AM, Richards P, Scholte-Voshaar M, Von Krause G, Kvien TK.

Ann Rheum Dis. 2009 Nov;68(11):1680-5. doi: 10.1136/ard.2008.100271. Epub 2008 Dec 3.

PMID:
19054825
15.

Melatonin treatment does not improve rheumatoid arthritis.

Maestroni GJ, Otsa K, Cutolo M.

Br J Clin Pharmacol. 2008 May;65(5):797-8. doi: 10.1111/j.1365-2125.2007.03088.x. Epub 2008 Feb 20. No abstract available.

16.

Review: vitamin D, immunity and lupus.

Cutolo M, Otsa K.

Lupus. 2008 Jan;17(1):6-10. Review.

PMID:
18089676
17.

Vitamin D in rheumatoid arthritis.

Cutolo M, Otsa K, Uprus M, Paolino S, Seriolo B.

Autoimmun Rev. 2007 Nov;7(1):59-64. doi: 10.1016/j.autrev.2007.07.001. Epub 2007 Aug 14. Review.

PMID:
17967727
18.

Vitamin D and rheumatoid arthritis: comment on the letter by Nielen et al.

Cutolo M, Otsa K, Yprus M, Seriolo B.

Arthritis Rheum. 2007 May;56(5):1719-20. No abstract available.

19.

Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe.

Cutolo M, Otsa K, Laas K, Yprus M, Lehtme R, Secchi ME, Sulli A, Paolino S, Seriolo B.

Clin Exp Rheumatol. 2006 Nov-Dec;24(6):702-4.

PMID:
17207389
20.

Circadian rhythms: glucocorticoids and arthritis.

Cutolo M, Sulli A, Pizzorni C, Secchi ME, Soldano S, Seriolo B, Straub RH, Otsa K, Maestroni GJ.

Ann N Y Acad Sci. 2006 Jun;1069:289-99. Review.

PMID:
16855156
21.

Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease's symptoms.

Cutolo M, Villaggio B, Otsa K, Aakre O, Sulli A, Seriolo B.

Autoimmun Rev. 2005 Nov;4(8):497-502. Epub 2005 Jun 13. Review.

PMID:
16214085
22.

Nocturnal hormones and clinical rhythms in rheumatoid arthritis.

Cutolo M, Otsa K, Aakre O, Sulli A.

Ann N Y Acad Sci. 2005 Jun;1051:372-81. Review.

PMID:
16126979
23.

Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison.

Cutolo M, Maestroni GJ, Otsa K, Aakre O, Villaggio B, Capellino S, Montagna P, Fazzuoli L, Veldi T, Peets T, Hertens E, Sulli A.

Ann Rheum Dis. 2005 Feb;64(2):212-6.

Supplemental Content

Support Center